Asthma - management

Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY
David Price, Ian D Pavord, Keith Peres Da Costa, Alvar Agustí, Gary P Anderson, Aruna T Bansal, Elisabeth H Bel, Malin Fagerås, Rod Hughes, Hiromasa Inoue, Glenda Lassi, José María Olaguibel, Alberto Papi, Marcelo Rabahi, Helen K Reddel, Adrian Rendon, Maarten Van Den Berge, Hana Müllerová

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3705; DOI: 10.1183/13993003.congress-2021.PA3705
Assessing the Asthma Impairment and Risk Questionnaire’s ability to predict exacerbations
David Beuther, Kevin R. Murphy, Robert S. Zeiger, Robert A. Wise, William Mccann, Joan Reibman, Maureen George, Ileen Gilbert, James M. Eudicone, Hitesh N. Gandhi, Melissa Ross, Karin S. Coyne, Bradley Chipps

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3714; DOI: 10.1183/13993003.congress-2021.PA3714
Comparison between long- and short-term participants in a Disease Management Program (DMP) Bronchial Asthma in North Rhine Westphalia in Germany
Arne Weber, Sabine Groos, Jens Kretschmann, Christine Macare, Hagen Bernd

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3712; DOI: 10.1183/13993003.congress-2021.PA3712
A systematic review of the proportion of adolescents recruited to RCTs of asthma treatments for adults and adolescents
Amy Nuttall, Emma Wilkinson, William Bedson, Ian Sinha, Paul Mcnamara

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3921; DOI: 10.1183/13993003.congress-2021.PA3921
Severe asthma outcomes over two years of therapy with mepolizumab
Lynn Elsey, Thomas Pantin, Leanne J Holmes, Gael Tavernier, Stephen J Fowler

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3737; DOI: 10.1183/13993003.congress-2021.PA3737
The effect of CPAP in asthma patients with SAHS
Gorane Iturricastillo, Elisa Martínez, José María Eiros, Pedro Landete, Elena Ávalos, Carolina Cisneros, Julio Ancochea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3579; DOI: 10.1183/13993003.congress-2021.PA3579
Real-World Experience with dupilumab in Severe Asthma: One year data from an Italian Named Patient Program
Santi Nolasco, Raffaele Campisi, Claudia Crimi, Nicola Scichilone, Morena Porto, Gabriella Guarnieri, Alberto Papi, Bianca Beghé, Pietro Impellizzeri, Nunzio Crimi

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3743; DOI: 10.1183/13993003.congress-2021.PA3743
Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis
Madeleine E Oliver, Sarah Poole, Catherine Borg, Clare Connolly, Ian D Pavord, Timothy S C Hinks, Simon Couillard

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3741; DOI: 10.1183/13993003.congress-2021.PA3741
Monoclonal antibody treatments for paediatric severe asthma–outcomes, attitudes and adherence
Megan Sheppard, Ajay Kevat, Louisa Owens, Melinda Gray

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3931; DOI: 10.1183/13993003.congress-2021.PA3931
Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE)
Frank Kanniess, Lilla Tamasi, Robert R. Mroz, Petros Bakakos, Susanne Tubis, Gustavo Resler Plat, Anat Shavit

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3729; DOI: 10.1183/13993003.congress-2021.PA3729

Main menu

User menu

Search

Asthma - management

Pages

Contact us